Dr. Matthew Smolin, Cardiologist at Montrose Memorial Hospital, recently treated a patient at MMH with the newly approved SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent from Boston Scientific making her one of the first patients in Colorado to benefit from this highly anticipated new technology. The SYNERGY Stent was approved for use by the FDA on 10/2/15. Stents are tiny mesh tubes doctors use to prop open clogged arteries, allowing blood to flow freely to the heart.
“Bringing the most advanced medical technologies to our community directly supports our mission to provide outstanding patient care,” said Dr. Smolin. “Early adoption of the SYNERGY Stent, the first and only bioabsorbable polymer drug eluting stent in the U.S., reinforces our commitment to deliver advanced treatment to patients in Montrose and the surrounding communities.”
Manufactured by Boston Scientific, the SYNERGY Stent, with its bioabsorbable polymer, offers simultaneous drug and polymer absorption. Designed for faster healing, the SYNERGY Stent offers what you need when you need it; medicine, which inhibits coronary blockages from recurring, and freedom from permanent polymer exposure, which has been associated with complications such as vessel re-narrowing and blood clots.